The current valuation score of DiaMedica Therapeutics Inc is 7.11, ranking 261 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -9.30, which is -72.56% below the recent high of -2.55 and -40.75% above the recent low of -13.09.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.